Back to results
US 2016/0089388 A1Published application
Cytotoxic agents for the treatment of cancer
AssigneeCytRx Corporation
InventorDaniel Levitt
Life of this patent
Estimating the term…
Abstract
The present invention relates to a method of treating brain cancer comprising administering a therapeutically effective substance to a patient, wherein the therapeutically effective substance comprises: (I), or a pharmaceutically acceptable salt thereof, wherein X is a moiety that can be cleaved hydrolvtically or enzymaticaily in the body of the patient in a pH-dependent manner.
Claims27
A method for the treatment of brain cancer comprising administering a therapeutically effective substance to a patient, wherein the therapeutically effective substance comprises:
- wherein X is a moiety that can be cleaved hydrolytically or enzymatically in the body of the patient in a pH-dependent manner.
19-72. (canceled)
Dependencies are inferred from the claim text.